Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome

OBJECTIVE: Patients with cardiorenal syndrome (CRS) have high cardiovascular morbidity. Endothelial progenitor cells (EPC) constitute an endogenous vascular repairsystem, protecting against atherosclerosis development. Erythropoietin (EPO) treatment may have beneficial effects by mobilizing EPC from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jie, Kim E, van der Putten, Karien, Bergevoet, Marloes W T, Doevendans, Pieter A, Gaillard, Carlo A J M, Braam, Branko, Verhaar, Marianne C
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2010
Assuntos:
Cardiorenal Syndrome
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002834/
https://ncbi.nlm.nih.gov/pubmed/21071558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2010.194654
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados